EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation and Feasibility of the Postnatal Growth and Retinopathy of Prematurity Retinal Screening Criteria at a Level IV Tertiary Care Neonatal Intensive Care Unit

Validierung und Machbarkeit der Postnatal Growth and Retinopathy of Prematurity (G-ROP)-Screeningkriterien bei der retinalen Untersuchung auf Frühgeborenenretinopathie in einer tertiären neonatologischen Intensivstation der Versorgungsstufe IV

Barbara Johnson iD, Abhishek Makkar, Rachel Sessler, Lise DeShea, R Michael Siatkowski, Faizah N Bhatti iD

American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e2376-e2382

DOI: 10.1055/a-2113-8733 ↗

Auf einen Blick

In einer retrospektiven Analyse erreichte G-ROP 100 % Sensitivität für Typ-1-ROP und 87,6 % für Typ-2-ROP. Die Zahl der untersuchten Frühgeborenen hätte sich um 50 % reduziert.

Fragestellung

Sollten die G-ROP-Kriterien bei Frühgeborenen >28 Schwangerschaftswochen die ROP-Screeninguntersuchungen sicher vorhersagen und könnten dadurch Kosten sinken?

Methode

Retrospektive Analyse von retinalen Screeningdaten; post-hoc Anwendung der G-ROP-Kriterien bei in den Jahren 2014 bis 2019 gescreenten Frühgeborenen >28 Schwangerschaftswochen; Auswertung von Sensitivität, Spezifität und potenziellen Kosteneinsparungen.

Ergebnisse

Eingeschlossen waren alle nach den Leitlinien der American Academy of Pediatric Ophthalmologists/American Academy of Pediatrics gescreenten Frühgeborenen >28 Schwangerschaftswochen. G-ROP hatte 100 % Sensitivität für Typ-1-ROP und 87,6 % für Typ-2-ROP; 50 % weniger Kinder wären gescreent worden. Alle behandlungsbedürftigen Fälle in der zweiten Stufe wurden erkannt; projizierte Kosteneinsparung 49 %.

Schlussfolgerung der Autor:innen

Die G-ROP-Kriterien sind im realen Versorgungsalltag einfach anwendbar und praktikabel. Sie erkannten alle Typ-1-ROP-Fälle, verfehlten jedoch einige Typ-2-ROP-Fälle.

Kernaussagen

  • 100 % Sensitivität für Typ-1-ROP
  • 87,6 % Sensitivität für Typ-2-ROP
  • 50 % weniger Screeninguntersuchungen; projizierte Kosteneinsparung 49 %

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Validierungsstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Barbara Johnson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Neonatal Perinatal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Intensive Care Units, Neonatal, Neonatal Screening, Feasibility Studies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: NCRR NIH HHS, NIGMS NIH HHS, Research to Prevent Blindness.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Retinopathy of prematurity (ROP) is detected in preterm infants by standardized screening programs, but in general, they have poor sensitivity. The Postnatal Growth and Retinopathy of Prematurity (G-ROP) algorithm uses weight gain to predict ROP superior reported sensitivity. Our objectives are to (1) independently validate the sensitivity of G-ROP criteria for the detection of ROP in infants born at >28 weeks' gestation in a tertiary care unit in the United States and (2) to calculate the cost savings associated with a potential reduction in examinations. Study Design This is a retrospective analysis of retinal screening examination data, with post-hoc application of G-ROP criteria to determine whether G-ROP criteria had acceptable sensitivity and specificity in diagnosing Type 1 and Type 2 ROP. All infants born at >28 weeks who were screened by current American Academy of Pediatric Ophthalmologists/American Academy of Pediatrics guidelines at Oklahoma Children's Hospital at the University of Oklahoma Health Sciences Center, between 2014 and 2019, were included. Subset analysis of infants screened by second tier criteria was also performed. Potential cost savings were estimated by analyzing frequency of billing codes. And by calculating the number of infants who could have potentially been spared examination.

Results

The G-ROP criteria had 100% sensitivity in detecting type 1 and 87.6% sensitivity in detecting type 2 ROP, which would have reduced infants screened by 50%. All infants in the second tier who would require treatment were detected. A cost saving of 49% was projected.

Conclusion

The G-ROP criteria are easy to apply in real-world setting, thus establishing feasibility. The algorithm identified all cases of type 1 ROP; however, some cases of type 2 ROP were not detected. The annual savings in hospital examination cost by using these criteria would be 50%. Therefore, G-ROP criteria can safely be used to screen for ROP and may reduce the number of unnecessary examinations. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinopathy of PrematurityIntensive Care Units, NeonatalNeonatal ScreeningFeasibility StudiesSensitivity and SpecificityHumansInfant, NewbornRetrospective StudiesFemaleMaleAlgorithmsTertiary Care CentersGestational AgeCost SavingsInfant, PrematureWeight Gain

Autor:innen und Institutionen

  • Department of Pediatrics, Neonatal Perinatal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Department of Ophthalmology and Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

ORCID-Profile: Barbara Johnson, Faizah N Bhatti

Förderung

  • NCRR NIH HHS
  • NIGMS NIH HHS
  • Research to Prevent Blindness
  • National Institutes of Health

Zitieren

APA

Johnson, B., Makkar, A., Sessler, R., DeShea, L., Siatkowski, R. M., & Bhatti, F. N. (2024). Validation and Feasibility of the Postnatal Growth and Retinopathy of Prematurity Retinal Screening Criteria at a Level IV Tertiary Care Neonatal Intensive Care Unit. American Journal of Perinatology, 41(S 01 S 01), e2376-e2382. https://doi.org/10.1055/a-2113-8733

Vancouver

Johnson B, Makkar A, Sessler R, DeShea L, Siatkowski RM, Bhatti FN. Validation and Feasibility of the Postnatal Growth and Retinopathy of Prematurity Retinal Screening Criteria at a Level IV Tertiary Care Neonatal Intensive Care Unit. American Journal of Perinatology. 2024;41(S 01 S 01):e2376-e2382. doi:10.1055/a-2113-8733

BibTeX
@article{Johnson2024,
  author = {Johnson, Barbara and Makkar, Abhishek and Sessler, Rachel and DeShea, Lise and Siatkowski, R Michael and Bhatti, Faizah N},
  title = {Validation and Feasibility of the Postnatal Growth and Retinopathy of Prematurity Retinal Screening Criteria at a Level IV Tertiary Care Neonatal Intensive Care Unit},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {S 01 S 01},
  pages = {e2376--e2382},
  doi = {10.1055/a-2113-8733}
}
Kostenlos starten →